Degeneration in the macula region of the retina is a feature of a heterogeneous group of inherited, progressive disorders, causing blinding visual impairment. Autosomal dominant Doyne's honeycomb retinal dystrophy (DHRD) is characterised by the presence of drusen deposits at the level of Bruch's membrane in the macula and around the edge of the optic nerve head. We have studied 63 members of a large, nine-generation British pedigree by linkage analysis. Two-point analysis showed significant linkage to nine markers on the short arm of chromosome 2, a region overlapping that recently reported to be linked to Malattia leventinese. A maximum lod score (Z max ) of 7.29 (θ = 0.0) was obtained at marker locus D2S2251. Haplotype analysis of recombination events localised the disease to a 5 cM region between marker loci D2S2316 and D2S378. Striking clinical similarities between DHRD and the more common condition age-related macular degeneration (ARMD) suggest that the disease gene at this locus could be considered as the most likely candidate in future studies on ARMD.
INTRODUCTION
Retinal degeneration focused on the macular region of the human retina is a feature of a number of different disorders, all of which result in colour blindness and loss of central vision sufficiently severe for blind registration. Morphological defects in the neurosensory retina, retinal pigment epithelium (RPE) and/or Bruch's membrane may be observed. Despite the large number of genomic loci which have been linked to specific retinal dystrophies that principally affect the macula (1-6), mutations in only two genes peripherin/RDS (7) (8) (9) (10) (11) (12) (13) (14) (15) and TIMP3 (6, (16) (17) (18) have so far been identified in this important group of disorders. Doyne's honeycomb retinal dystrophy (DHRD) (19) (20) (21) ) is a disease that leads to 'drusen' deposits in the macula. Malattia leventinese is also characterised by drusen but is considered distinct from DHRD because of differences in drusen composition and distribution (22, 23) . Malattia leventinese has recently been localised to the short arm of chromosome 2 (24) . These two conditions together with Hutchinson-Tay choroiditis (25) and Holthouse-Batten chorioretinitis (26) have been denoted by the collective term dominantly inherited drusen (23) , although it is unknown how many different nosological entities they may represent. Members of the original families expressing the DHRD phenotype that were studied by Doyne (19) and Pearce (21) were contacted ( Fig. 1 ) and a molecular genetic linkage study was undertaken. Our findings demonstrate that the DHRD gene maps to chromosome 2p16.
RESULTS
Loci implicated in previous studies on autosomal dominant macular dystrophy were excluded in this family as part of a total genome search comprising 228 markers, before linkage was obtained to chromosome 2 at marker locus D2S378. Linkage of the DHRD locus to chromosome 2p was established by genotyping nine other marker loci in the region, of which significant linkage was obtained at eight. Two-point lodscores with marker loci mapping to chromosome 2p are presented in Table 1 . The highest lodscore calculated (9.49 at θ = 0.06) was obtained with marker locus D2S378.
Haplotypes across the linked region were constructed for all family members and analysis of recombinants (Fig. 2) localised the DHRD gene to a 5 cM interval between D2S2316 (one recombination event) and D2S378 (two recombinant events). This establishes a more precise mapping of the disease gene to chromosome 2p16 (27) . Three affected individuals (VII-33, VII-34 and VII-36) were recombinant at marker locus D2S2316. All of these patients had the same recombinant allele at this locus and were descended from one branch of the pedigree [originally described as family A2 (21)], suggesting that a single *To whom correspondence should be addressed recombination event had occurred in a common ancestor (III-3). Four other affected individuals (VII-24, VII-26, VII-27 and VII-28) were recombinant at marker locus D2S378. Inspection of the haplotypes again suggested a single recombination event in a common ancestor (VI-11). In addition, one unaffected individual (VII-8) was recombinant at locus D2S378. 
DISCUSSION
We have demonstrated by linkage analysis that the DHRD disease-gene is localised to a 5 cM interval on the short arm of chromosome 2 in the region 2p16. Of the genes which map to this region centromeric to marker locus D2S119 (28, 29) , calmodulin-2 (CALM2) is the best potential candidate gene. Calmodulin is known to be expressed in the retina (30) and interacts with calcium to modulate phototransduction (31) . Mutations in other phototransduction genes such as rhodopsin (32) and cGMP-phosphodiesterase (33) have previously been associated with retinal dystrophies in humans. That a disease thought to affect primarily the retinal pigment epithelium (RPE) should be due to a mutation in a gene expressed in the photoreceptor cells would be unexpected. However, the example of peripherin/RDS giving rise to pattern dystrophy of the RPE exists (12, 34) . One RPE-expressed gene (35, 36) , the non-erythrocyte form of β-spectrin, β-fodrin (SPTBN1) (37) maps close to this region, but may be excluded as a candidate gene for DHRD by the recombination events with marker loci D2S391, D2S2227 and D2S2316, which convincingly map the DHRD locus centromeric to the locus assigned to this gene. Human 2p16 is syntenic with a region of mouse chromosome 11 (The Mouse Genome database, 1995); however, no mouse genes in the syntenic region between Mor2 (malate dehydrogenase) and Rel (reticuloendotheliosis oncogene) could be considered as good candidates for DHRD. Four other disorders map close to the region assigned to DHRD. Congenital glaucoma (GLC3A) (38) , holoprosencephaly type 2 (HPE2) (39), hereditary nonpolyposis colorectal cancer (COCA1) (40) and Malattia leventinese (24) . The genetic map of this region can be summarised as tel-D2S367-GLC3A-D2S119-HPE2-
D2S391-COCA1-D2S2316-DHRD-D2S378-D2S444-cen.
The Malattia leventinese locus has been assigned to a 14 cM region flanked by D2S1761 (between D2S119 and D2S391) and D2S444 (24) , encompassing the loci COCA1 and DHRD. Mapping data and some clinical similarities between DHRD and Malattia leventinese might suggest that they could be allelic. However, important differences at present make this suggestion premature. Clinical studies of these conditions have described differences in the form and distribution of drusen deposits (26) . In Malattia leventinese there are small discrete drusen seen radiating into the peripheral retina, with the later development of confluent soft drusen at macula. These ophthalmoscopic features have been consistently and invariably reported in patients affected with the condition (22, 23, 26) , and histopathological studies (41, 42) have established that the radial deposits are continuous with or internal to the basement membrane of the retinal pigment epithelium (RPE). In contrast large, soft drusen deposits affecting the macula and peridiscal areas are seen in DHRD (19,21) which have been described histologically (20) as external to the basement membrane of the RPE, occupying the entire thickness of Bruch's membrane. Radial drusen extending into the periphery have not been described in DHRD. These morphological studies suggest that the deposits seen in the two conditions are different in both localisation and composition and may result from different biochemical abnormalities. In view of these differences future linkage studies and physical mapping projects on the region should not assume that one dominant drusen disease-gene exists in the region.
Macular drusen are also an important feature of age-related macular degeneration (ARMD) (43) . The importance of dominant drusen disorders is their potential homology with ARMD (43,44), a complex genetic disorder (45-47) which accounts for 50% of blind registration in the developed world (48, 49) . No genomic locus or genetic mutation has yet been identified in ARMD. The present study strengthens the importance of chromosome 2p21-p16 in the development of dominant drusen phenotypes and the locus should now be considered the best candidate region for disease susceptibility genes in ARMD. Assessment of the CALM2 gene as the defective gene in this DHRD family is currently underway and a YAC contig of the region is under construction, to facilitate the cloning of the DHRD gene. Additionally, we are screening other dominant drusen families from the Moorfields Register to determine whether genetic heterogeneity is associated with this phenotype.
MATERIALS AND METHODS

Clinical studies
Information from living descendants and genealogical techniques (50) were used to construct a single, nine-generation pedigree consisting of over 400 individuals derived from Buckinghamshire in the United Kingdom (Fig. 1) . One hundred and nineteen members of the DHRD family were examined by two ophthalmologists (KE and ACB). Each patient had standard diagnostic ocular examinations including indirect ophthalmoscopy and fluorescein angiography. The results of clinical evaluations and ophthalmological examinations are described in detail elsewhere (21 and K. Evans et al., in preparation) .
Affected status was assigned by the observation of soft drusen deposits at the macula and more importantly the appearance of drusen around the optic nerve head, a feature considered pathonomonic for DHRD. Allocation of unaffected status was more difficult since it could not be assumed that a normal clinical examination at <30 years of age indicated that the patient was unaffected and drusen deposits can be a common sign of other conditions. Unaffected status was therefore reserved for individuals over 45 years of age who had no deposits, on critical clinical examination. Many individuals failed to satisfy these criteria and were excluded from the linkage analysis. An abbreviated pedigree illustrating the relationships between the individuals enrolled into the molecular genetic study is given in Figure 1 , which clearly demonstrates autosomal dominant inheritance of the disease. The branches of the pedigree reported by Pearce (21) are identified using his original classification (A1, A2 and C). Difficulties in disease allocation as described above meant that the linkage panel of family members originated mostly from one generation and were linked genealogically through a number of unsampled generations. A total of 35 affected individuals, 20 unaffected individuals and eight spouses were enrolled into the study. Local ethical committee approval and informed consent from each patient was obtained prior to the molecular genetic study.
Genotyping
Peripheral blood samples were taken from patients and genomic DNA was extracted with a Nucleon II DNA extraction kit (Scotlab, Bioscience). Genotyping was performed across the entire genome at 10-20 cM intervals as previously described (51) , with 228 microsatellite markers that were selected from Généthon (52, 53) , the Collaborative Human Linkage Center (CHLC) and from the published literature.
Linkage analysis
Data were prepared for linkage analysis using the LINKSYS (version 3.1) data management package (54) . Two-point linkage analysis was performed with the MLINK programme (version 5.10) of the LINKAGE package (55) . Allele frequencies were calculated from eight spouses in the family.
